STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few

According to STAT, a promising therapy for Duchenne muscular dystrophy is currently available to only a fortunate few patients. The article notes that exon-skipping drugs present a critical test for the FDA's goal of encouraging treatments for rare diseases.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.